- Home
- ACAD vs GLNG Comparison
ACAD vs GLNG Comparison
Compare ACAD & GLNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACAD
- GLNG
- Stock Information
- Founded
- ACAD 1993
- GLNG 1946
- Country
- ACAD United States
- GLNG Bermuda
- Employees
- ACAD N/A
- GLNG N/A
- Industry
- ACAD Biotechnology: Pharmaceutical Preparations
- GLNG Marine Transportation
- Sector
- ACAD Health Care
- GLNG Consumer Discretionary
- Exchange
- ACAD Nasdaq
- GLNG Nasdaq
- Market Cap
- ACAD 4.3B
- GLNG 4.2B
- IPO Year
- ACAD 2004
- GLNG N/A
- Fundamental
- Price
- ACAD $21.31
- GLNG $38.21
- Analyst Decision
- ACAD Buy
- GLNG Strong Buy
- Analyst Count
- ACAD 21
- GLNG 3
- Target Price
- ACAD $29.25
- GLNG $51.17
- AVG Volume (30 Days)
- ACAD 2.3M
- GLNG 1.2M
- Earning Date
- ACAD 11-05-2025
- GLNG 01-01-0001
- Dividend Yield
- ACAD N/A
- GLNG 2.61%
- EPS Growth
- ACAD 615.00
- GLNG N/A
- EPS
- ACAD 1.33
- GLNG N/A
- Revenue
- ACAD $1,018,885,000.00
- GLNG $268,899,000.00
- Revenue This Year
- ACAD $14.01
- GLNG $56.46
- Revenue Next Year
- ACAD $11.81
- GLNG $0.17
- P/E Ratio
- ACAD $16.07
- GLNG N/A
- Revenue Growth
- ACAD 14.41
- GLNG N/A
- 52 Week Low
- ACAD $13.40
- GLNG $29.56
- 52 Week High
- ACAD $26.65
- GLNG $45.98
- Technical
- Relative Strength Index (RSI)
- ACAD 33.94
- GLNG 34.43
- Support Level
- ACAD $21.32
- GLNG $38.40
- Resistance Level
- ACAD $21.96
- GLNG $41.65
- Average True Range (ATR)
- ACAD 0.60
- GLNG 0.90
- MACD
- ACAD -0.10
- GLNG -0.16
- Stochastic Oscillator
- ACAD 30.11
- GLNG 3.08
About ACAD ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has two core franchises in neuroscience and neuro-rare diseases. The neuroscience franchise is anchored by its commercial product NUPLAZID (pimavanserin), which is used for the treatment of hallucinations and delusions associated with Parkinson's Disease Psychosis (PDP). The neuro-rare disease franchise is anchored by the commercial product DAYBUE, which is used for the treatment of Rett syndrome. In addition, the company has various product candidates under development in different stages, including ACP-204, ACP-101, ACP-211, ACP-711, ACP-2591, etc.
About GLNG Golar Lng Ltd
Golar LNG Ltd is a midstream LNG company that operates in the transportation, regasification, liquefaction, and trading of LNG. The segment in which the group operates includes Shipping, FLNG (Floating Liquefaction Natural Gas vessels), and Corporate and other. It generates maximum revenue from the FLNG segment.